Xanthine Oxidase Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Morin anhydrous | 480-16-0 | sc-205955 sc-205955A | 1 g 5 g | $32.00 $51.00 | 1 | |
Morin anhydrous acts as a potent inhibitor of xanthine oxidase, showcasing unique molecular interactions that disrupt the enzyme's catalytic activity. Its structure allows for specific binding to the active site, altering the enzyme's conformation and reducing the formation of reactive oxygen species. The compound exhibits notable reaction kinetics, with a competitive inhibition profile that influences metabolic pathways, thereby modulating purine metabolism and oxidative stress responses. | ||||||
Febuxostat | 144060-53-7 | sc-207680 | 10 mg | $168.00 | 3 | |
Febuxostat is a xanthine oxidase inhibitor for gout treatment. It reduces uric acid levels by inhibiting the activity of xanthine oxidase. | ||||||
Purpurin | 81-54-9 | sc-205822 sc-205822A sc-205822B sc-205822C | 5 g 25 g 100 g 250 g | $46.00 $161.00 $398.00 $867.00 | ||
Purpurin functions as an effective xanthine oxidase inhibitor, characterized by its ability to form stable complexes with the enzyme. This interaction alters the enzyme's active site dynamics, leading to a decrease in uric acid production. The compound's unique structural features facilitate strong π-π stacking and hydrogen bonding, enhancing its binding affinity. Additionally, Purpurin exhibits distinct reaction kinetics, demonstrating non-competitive inhibition that impacts cellular redox balance and metabolic flux. | ||||||
Allopurinol | 315-30-0 | sc-207272 | 25 g | $128.00 | ||
Allopurinol is one of the most commonly used xanthine oxidase inhibitors. It is a first-line medication for gout and helps prevent the formation of uric acid crystals in joints. | ||||||
Caffeic Acid | 331-39-5 | sc-200499 sc-200499A | 1 g 5 g | $31.00 $61.00 | 1 | |
Caffeic acid acts as a xanthine oxidase inhibitor through its ability to interact with the enzyme's active site, disrupting substrate binding. Its phenolic structure allows for effective hydrogen bonding and hydrophobic interactions, which stabilize the enzyme-inhibitor complex. This compound exhibits mixed inhibition kinetics, influencing both the enzyme's affinity for its substrates and the overall reaction rate. Additionally, its antioxidant properties may modulate oxidative stress pathways, further impacting metabolic processes. | ||||||
Allopurinol-d2 | 916979-34-5 | sc-207273 | 2.5 mg | $360.00 | ||
Allopurinol-d2 functions as a xanthine oxidase inhibitor by selectively binding to the enzyme's active site, altering its conformation and reducing its catalytic efficiency. The deuterated form enhances stability and alters reaction kinetics, providing insights into enzyme mechanisms. Its unique isotopic labeling allows for advanced spectroscopic studies, revealing intricate molecular interactions and dynamics. This compound's distinct behavior in metabolic pathways highlights its role in modulating purine metabolism. | ||||||
Bendazac | 20187-55-7 | sc-337553 | 5 g | $180.00 | ||
Bendazac acts as a xanthine oxidase inhibitor through its ability to form non-covalent interactions with the enzyme, disrupting substrate binding and altering electron transfer processes. Its unique structural features facilitate specific interactions with key amino acid residues, influencing the enzyme's catalytic activity. The compound's kinetic profile reveals a competitive inhibition mechanism, providing insights into the regulation of purine degradation pathways and the modulation of reactive oxygen species. | ||||||